1. Home
  2. CIF vs HBIO Comparison

CIF vs HBIO Comparison

Compare CIF & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Intermediate High Income Fund

CIF

MFS Intermediate High Income Fund

HOLD

Current Price

$1.63

Market Cap

29.4M

Sector

Finance

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.40

Market Cap

25.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIF
HBIO
Founded
1988
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
25.7M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CIF
HBIO
Price
$1.63
$5.40
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
51.6K
36.7K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
10.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$0.28
52 Week High
$1.82
$7.50

Technical Indicators

Market Signals
Indicator
CIF
HBIO
Relative Strength Index (RSI) 49.38 45.05
Support Level N/A $4.42
Resistance Level $1.73 $5.79
Average True Range (ATR) 0.02 0.46
MACD 0.00 -0.25
Stochastic Oscillator 50.00 10.76

Price Performance

Historical Comparison
CIF
HBIO

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment-grade corporate bonds, government securities and other securities. The portfolio includes Midstream, Financial Institutions, Energy, Cable TV, and Utilities.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: